Achieve Life Sciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Achieve Life Sciences, Inc. (ACHV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 7.03 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-11
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 4.72M shares, a 2396.66% increase year-over-year.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 2.31M shares, a 1755.34% increase year-over-year.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 616.00K shares, a 191.94% increase year-over-year.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 929.50K shares, a 37.20% increase from fiscal 2024.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 677.50K shares, a 5.94% increase from fiscal 2023.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 639.50K shares, a 112.85% increase from fiscal 2022.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 300.45K shares, a 1.97% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 4.72M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 7.03M shares 10-Q · filed 2026-08-11 | 7.64M shares derived: sum of 3 quarters · filed 2026-08-11 | 7.64M shares derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | 2.31M shares 10-Q · filed 2026-05-12 | 2.93M shares derived: sum of 2 quarters · filed 2026-05-12 | 2.93M shares derived: sum of 3 quarters · filed 2026-05-12 | 3.11M shares derived: sum of 4 quarters · filed 2026-05-12 | |
| 2025-12-31 | 616.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 616.00K shares derived: sum of 2 quarters · filed 2026-03-24 | 805.00K shares derived: sum of 3 quarters · filed 2026-03-24 | 929.50K shares 10-K · filed 2026-03-24 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 189.00K shares derived: sum of 2 quarters · filed 2025-11-06 | 313.50K shares 10-Q · filed 2025-11-06 | 524.50K shares derived: sum of 4 quarters · filed 2025-11-06 | |
| 2025-06-30 | 189.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 313.50K shares 10-Q · filed 2025-08-07 | 524.50K shares derived: sum of 3 quarters · filed 2025-08-07 | 524.50K shares derived: sum of 4 quarters · filed 2025-08-07 | |
| 2025-03-31 | 124.50K shares 10-Q · filed 2025-05-13 | 335.50K shares derived: sum of 2 quarters · filed 2025-05-13 | 335.50K shares derived: sum of 3 quarters · filed 2025-05-13 | 335.50K shares derived: sum of 4 quarters · filed 2025-05-13 | |
| 2024-12-31 | 211.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 211.00K shares derived: sum of 2 quarters · filed 2025-03-11 | 211.00K shares derived: sum of 3 quarters · filed 2025-03-11 | 677.50K shares 10-K · filed 2025-03-11 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-07 | 466.50K shares 10-Q · filed 2024-11-07 | 466.50K shares derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 466.50K shares 10-Q · filed 2024-08-13 | 466.50K shares derived: sum of 3 quarters · filed 2024-08-13 | 466.50K shares derived: sum of 4 quarters · filed 2024-08-13 | |
| 2024-03-31 | 466.50K shares 10-Q · filed 2024-05-09 | 466.50K shares derived: sum of 2 quarters · filed 2024-05-09 | 466.50K shares derived: sum of 3 quarters · filed 2024-05-09 | 599.25K shares derived: sum of 4 quarters · filed 2024-05-09 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-28 | 132.75K shares derived: sum of 3 quarters · filed 2024-03-28 | 639.50K shares 10-K · filed 2024-03-28 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 132.75K shares derived: sum of 2 quarters · filed 2023-11-09 | 639.50K shares 10-Q · filed 2023-11-09 | 639.50K shares derived: sum of 4 quarters · filed 2023-11-09 | |
| 2023-06-30 | 132.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 639.50K shares 10-Q · filed 2023-08-14 | 639.50K shares derived: sum of 3 quarters · filed 2023-08-14 | 639.50K shares derived: sum of 4 quarters · filed 2023-08-14 | |
| 2023-03-31 | 506.75K shares 10-Q · filed 2023-05-09 | 506.75K shares derived: sum of 2 quarters · filed 2023-05-09 | 506.75K shares derived: sum of 3 quarters · filed 2023-05-09 | 539.35K shares derived: sum of 4 quarters · filed 2023-05-09 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-16 | 32.60K shares derived: sum of 3 quarters · filed 2023-03-16 | 300.45K shares 10-K · filed 2023-03-16 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 32.60K shares derived: sum of 2 quarters · filed 2022-11-14 | 300.45K shares 10-Q · filed 2022-11-14 | 300.45K shares derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-06-30 | 32.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 300.45K shares 10-Q · filed 2022-08-11 | 300.45K shares derived: sum of 3 quarters · filed 2022-08-11 | 345.45K shares derived: sum of 4 quarters · filed 2022-08-11 | |
| 2022-03-31 | 267.85K shares 10-Q · filed 2022-05-12 | 267.85K shares derived: sum of 2 quarters · filed 2022-05-12 | 312.85K shares derived: sum of 3 quarters · filed 2022-05-12 | 324.10K shares derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 45.00K shares derived: sum of 2 quarters · filed 2022-03-10 | 56.25K shares derived: sum of 3 quarters · filed 2022-03-10 | 294.65K shares 10-K · filed 2022-03-10 | |
| 2021-09-30 | 45.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 56.25K shares derived: sum of 2 quarters · filed 2021-11-09 | 294.65K shares 10-Q · filed 2021-11-09 | 392.65K shares derived: sum of 4 quarters · filed 2021-11-09 | |
| 2021-06-30 | 11.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 249.65K shares 10-Q · filed 2021-08-12 | 347.65K shares derived: sum of 3 quarters · filed 2021-08-12 | 347.65K shares derived: sum of 4 quarters · filed 2021-08-12 | |
| 2021-03-31 | 238.40K shares 10-Q · filed 2021-05-13 | 336.40K shares derived: sum of 2 quarters · filed 2021-05-13 | 336.40K shares derived: sum of 3 quarters · filed 2021-05-13 | -1.08M shares derived: sum of 4 quarters · filed 2021-05-13 | |
| 2020-12-31 | 98.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 98.00K shares derived: sum of 2 quarters · filed 2021-03-11 | -1.32M shares derived: sum of 3 quarters · filed 2021-03-11 | 178.38K shares 10-K · filed 2021-03-11 | |
| 2020-09-30 | 3.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -1.42M shares derived: sum of 2 quarters · filed 2020-11-12 | 80.38K shares 10-Q · filed 2020-11-12 | 80.38K shares derived: sum of 4 quarters · filed 2020-11-12 | |
| 2020-06-30 | -1.42M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 80.38K shares 10-Q · filed 2020-08-06 | 80.38K shares derived: sum of 3 quarters · filed 2020-08-06 | 80.38K shares derived: sum of 4 quarters · filed 2020-08-06 | |
| 2020-03-31 | 1.50M shares 10-Q · filed 2020-05-14 | 1.50M shares derived: sum of 2 quarters · filed 2020-05-14 | 1.50M shares derived: sum of 3 quarters · filed 2020-05-14 | 1.54M shares derived: sum of 4 quarters · filed 2020-05-14 | |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 0.00 shares derived: sum of 2 quarters · filed 2020-03-13 | 43.25K shares derived: sum of 3 quarters · filed 2020-03-13 | 345.35K shares 10-K · filed 2020-03-13 | |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 43.25K shares derived: sum of 2 quarters · filed 2019-11-06 | 345.35K shares 10-Q · filed 2019-11-06 | 345.35K shares derived: sum of 4 quarters · filed 2019-11-06 | |
| 2019-06-30 | 43.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 345.35K shares 10-Q · filed 2019-08-08 | 345.35K shares derived: sum of 3 quarters · filed 2019-08-08 | 899.75K shares derived: sum of 4 quarters · filed 2019-08-08 | |
| 2019-03-31 | 302.10K shares 10-Q · filed 2019-05-15 | 302.10K shares derived: sum of 2 quarters · filed 2019-05-15 | 856.50K shares derived: sum of 3 quarters · filed 2019-05-15 | 856.50K shares derived: sum of 4 quarters · filed 2019-05-15 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | 554.40K shares derived: sum of 2 quarters · filed 2019-03-14 | 554.40K shares derived: sum of 3 quarters · filed 2019-03-14 | 554.40K shares 10-K · filed 2019-03-14 | |
| 2018-09-30 | 554.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 554.40K shares derived: sum of 2 quarters · filed 2018-11-07 | 554.40K shares 10-Q · filed 2018-11-07 | 554.40K shares derived: sum of 4 quarters · filed 2018-11-07 | |
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-08 | 0.00 shares 10-Q · filed 2019-08-08 | 0.00 shares derived: sum of 3 quarters · filed 2018-08-08 | 1.05M shares derived: sum of 4 quarters · filed 2018-08-08 | |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-09 | 0.00 shares derived: sum of 2 quarters · filed 2018-05-09 | 1.05M shares derived: sum of 3 quarters · filed 2018-05-09 | 1.05M shares derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 1.05M shares derived: sum of 2 quarters · filed 2018-03-01 | 1.05M shares derived: sum of 3 quarters · filed 2018-08-08 | 1.05M shares 10-K · filed 2018-03-01 | |
| 2017-09-30 | 1.05M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 1.05M shares derived: sum of 2 quarters · filed 2018-08-08 | 1.05M shares 10-Q · filed 2017-11-09 | 2.69M shares derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-06-30 | 0.00 shares 10-Q · filed 2018-08-08 | 0.00 shares 10-Q · filed 2018-08-08 | 1.64M shares derived: sum of 3 quarters · filed 2018-08-08 | 0.00 shares derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-09 | 1.64M shares derived: sum of 2 quarters · filed 2018-05-09 | 0.00 shares derived: sum of 3 quarters · filed 2018-05-09 | 121.50K shares derived: sum of 4 quarters · filed 2018-05-09 | |
| 2016-12-31 | 1.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-09 | 121.50K shares derived: sum of 3 quarters · filed 2017-11-09 | 1.64M shares 10-K · filed 2017-02-23 | |
| 2016-09-30 | -1.64M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -1.51M shares derived: sum of 2 quarters · filed 2017-11-09 | 0.00 shares 10-Q · filed 2017-11-09 | 1.64M shares 10-Q · filed 2016-11-10 | 8.75K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | 121.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 1.64M shares 10-Q · filed 2016-08-04 | 1.64M shares derived: sum of 3 quarters · filed 2017-02-23 | 1.68M shares derived: sum of 4 quarters · filed 2017-02-23 | |
| 2016-03-31 | 1.51M shares 10-Q · filed 2016-05-12 | 1.52M shares derived: sum of 2 quarters · filed 2017-02-23 | 1.56M shares derived: sum of 3 quarters · filed 2017-02-23 | ||
| 2015-12-31 | 8.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 45.25K shares derived: sum of 2 quarters · filed 2017-02-23 | 502.05K shares 10-K · filed 2017-02-23 | ||
| 2015-09-30 | 36.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 493.30K shares 10-Q · filed 2015-11-12 | |||
| 2015-06-30 | 456.80K shares 10-Q · filed 2015-08-13 | ||||
| 2014-12-31 | 26.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 97.00K shares derived: sum of 2 quarters · filed 2017-02-23 | 122.00K shares derived: sum of 3 quarters · filed 2017-02-23 | 382.10K shares 10-K · filed 2017-02-23 | |
| 2014-09-30 | 71.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | 96.00K shares derived: sum of 2 quarters · filed 2014-10-30 | 356.10K shares 10-Q · filed 2014-10-30 | 386.10K shares derived: sum of 4 quarters · filed 2016-03-09 | |
| 2014-06-30 | 25.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 285.10K shares 10-Q · filed 2014-08-07 | 315.10K shares derived: sum of 3 quarters · filed 2016-03-09 | 315.10K shares derived: sum of 4 quarters · filed 2016-03-09 | |
| 2014-03-31 | 260.10K shares 10-Q · filed 2014-04-30 | 290.10K shares derived: sum of 2 quarters · filed 2016-03-09 | 290.10K shares derived: sum of 3 quarters · filed 2016-03-09 | 317.20K shares derived: sum of 4 quarters · filed 2016-03-09 | |
| 2013-12-31 | 30.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | 30.00K shares derived: sum of 2 quarters · filed 2016-03-09 | 57.10K shares derived: sum of 3 quarters · filed 2016-03-09 | 239.28K shares 10-K · filed 2016-03-09 | |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | 27.10K shares derived: sum of 2 quarters · filed 2013-11-07 | 209.28K shares 10-Q · filed 2013-11-07 | 224.08K shares derived: sum of 4 quarters · filed 2015-03-26 | |
| 2013-06-30 | 27.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 209.28K shares 10-Q · filed 2013-08-08 | 224.08K shares derived: sum of 3 quarters · filed 2015-03-26 | 234.68K shares derived: sum of 4 quarters · filed 2015-03-26 | |
| 2013-03-31 | 182.18K shares 10-Q · filed 2013-05-02 | 196.98K shares derived: sum of 2 quarters · filed 2015-03-26 | 207.58K shares derived: sum of 3 quarters · filed 2015-03-26 | ||
| 2012-12-31 | 14.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | 25.40K shares derived: sum of 2 quarters · filed 2015-03-26 | 172.65K shares 10-K · filed 2015-03-26 | ||
| 2012-09-30 | 10.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | 157.85K shares 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | 147.25K shares 10-Q · filed 2012-08-02 | ||||
| 2011-12-31 | 101.60K shares 10-K · filed 2014-03-11 | ||||
| 2010-12-31 | 170.87K shares 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |